Group One Trading’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Group One Trading’s Portfolio EVLO Stock Details EVLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,315	Closed	-$55K	–	8366
2022 Q3	$55K	Hold	1,315	–	–	﹤0.01%	5334
2022 Q2	$55K	Buy	+1,315	New	+$61K	﹤0.01%	5476
2022 Q1	–	Sell	-5,900	Closed	-$716K	–	8992
2021 Q4	$716K	Buy	5,900 +2,430	+70%	+$410K	﹤0.01%	3702
2021 Q3	$489K	Buy	+3,470	New	+$688K	﹤0.01%	4207

Other funds holding EVLO

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Group One Trading's EVLO Position: Q4 2023 in Review

Group One Trading sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q4 2023, closing a stake of 16 shares — an estimated $63 sold.

Group One Trading first reported a position in EVLO in Q4 2021 and held it in 6 quarters. The position peaked at $1.53M in Q1 2022. 2 funds tracked by Wall St. Rank hold EVLO as of Q4 2023.

Group One Trading reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Group One Trading sold 16 Evelo Biosciences, Inc. Common Stock shares in Q4 2023, an estimated $63.
Group One Trading first reported a position in Evelo Biosciences, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
Group One Trading's Evelo Biosciences, Inc. Common Stock position peaked at $1.53M in Q1 2022.
2 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q4 2023.

Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.